Citations

Clear

14 citation(s) found for "Scott, Gregory".

The NCDR CathPCI Registry: a US national perspective on care and outcomes for percutaneous coronary intervention
Moussa, Issam , Hermann, Anthony, Messenger, John C. , Dehmer, Gregory , Weaver, W. Douglas, Rumsfeld, John S., Masoudi, Frederick A.

Mayo Clinic

Heart | January 15, 2013 | Volume: 99 | Issue: 5 | Pages: 297-303

10.1136/heartjnl-2012-303379 | PMID 23322530 Get It

Aims: The NCDR CathPCI Registry collects detailed clinical, process-of-care and outcomes data for patients undergoing coronary angiography and percutaneous coronary intervention (PCI) in the USA. The registry contributes to quality of care by providing data feedback on a wide range of performance metrics to participating centres and by facilitating local and national quality improvement efforts. Interventions: No treatments are mandated, participating centres receive routine quality-of-care and outcomes performance feedback reports and access to a quality dashboard for personalized performance reports. Population: Patients undergoing cardiac catheterization and PCI are retrospectively identified. No informed consent is required, as data are anonymised. From inception in 1998, more than 12 million records have been submitted from 1577 participating US centres. Baseline data: Approximately 250 fields encompassing patient demographics, medical history and risk factors, hospital presentation, initial cardiac status, procedural details, medications, laboratory values, and in-hospital outcomes. Linkages with outside sources of data have permitted longitudinal outcomes assessment in some cases. Centre personnel enter the data into the registry, in some cases facilitated by software vendors. There are non-financial incentives for centre participation. Data completeness is noteworthy with most fields missing at rates less than 5%. A comprehensive data quality program is employed to enhance data validity. Endpoints: Main outcome measures include quality process metrics and in-hospital patient outcomes. Data are available for research by application to: http://www.ncdr.com
Definitive therapy for prostate carcinoma: Mayo Clinic results at 15 years after treatment
Swanson, Gregory P. , Cupps, Roger E., Utz, David C., Ilstrup, D M, Zincke, Horst, Myers, Robert P., Swanson, Gregory P

Mayo Clinic

The British Journal of Radiology | July 15, 2009 | Volume: 67 | Issue: 801 | Pages: 877-889

10.1259/0007-1285-67-801-877 | PMID 7953230 Get It

Abstract Data on long-term follow-up for definitive therapy of prostate cancer are limited, especially for radiation therapy. Either surgery or radiation was used in 322 patients for treatment with curative intent, and follow-up was for a minimum of 15 years. Overall survival was nearly identical to that in an age-matched cohort. 5-, 10-, and 15-year recurrence-free survival rates were 77%, 63% and 53%, respectively. Grade and stage were significant prognostic factors for both recurrence and survival. More than 60% of the initial failures were local, and more than 25% of the failures occurred after 10 years. Radiation therapy was used in 137 patients with clinically staged disease. Radical retropubic prostatectomy and perineal prostatectomy were performed in 133 and 44 patients, respectively. In this group, pathological staging was used. Survival rates for surgically treated patients were better than those in the cohort population. In conclusion, overall long-term follow-up demonstrates that definitive treatment does not have an adverse effect on survival from prostate cancer. Local recurrence is a frequent cause of failure. Caution must be used in interpreting any prostate study with less than 10 years of follow-up, because 25% to 50% of the failures occur after that time.
Staging of Bone Tumors: A Review with Illustrative Examples
Stacy, Gregory Scott , Mahal, Ravinder S., Peabody, Terrance D.

Mayo Clinic

American Journal of Roentgenology | March 23, 2006 | Volume: 186 | Issue: 4 | Pages: 967-976

10.2214/ajr.05.0654 | PMID 16554565 Get It

FAILURE AFTER PRIMARY RADIATION OR SURGERY FOR PROSTATE CANCER: DIFFERENCES IN RESPONSE TO ANDROGEN ABLATION
Swanson, Gregory P. , Riggs, Mark W., Earle, John D., Swanson, Gregory P

Mayo Clinic

Journal of Urology | July 2, 2004 | Volume: 172 | Issue: 2 | Pages: 525-528

10.1097/01.ju.0000132412.74468.57 | PMID 15247720 Get It